课题基金 / 基金详情

MICRORNA PREDICTORS OF OESOPHAGEAL TUMOUR RESPONSE TO CHEMOTHERAPY AND RADIOTHERAPY

MICRORNA PREDICTORS OF OESOPHAGEAL TUMOUR RESPONSE TO CHEMOTHERAPY AND RADIOTHERAPY
食管肿瘤对化疗和放疗反应的微小RNA预测因子
批准号:
nhmrc : 595964
负责人:
A/Pr Michael Michael
金额:
$44.01万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2012-12-31

项目摘要

项目成果

A/Pr Michael Michael的其他基金

相似基金

相关文献

中文摘要
翻译
放化疗(CRT)用于食管癌手术切除前的治疗,以及未接受手术的患者。然而,对许多人来说,这是不成功的,会产生副作用,没有临床效果,并延迟手术。microrna是控制细胞功能的小分子。该项目将确定能够预测癌症对CRT反应的miRNA标记物,这将有助于个体化治疗的临床决策。
英文摘要
Chemoradiotherapy (CRT) is used for the treatment of oesophageal cancer before surgical resection, and for patients not undergoing surgery. However, it is unsuccessful for many, causing side effects, no clinical gain, and delaying surgery. MicroRNAs are small molecules that control cellular functions. This project will identify miRNA markers which are able to predict cancer response to CRT, and this will help clinical decision making for individualized treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Resistance to Immunological Targeting of Primary and Metastatic Colorectal Cancers
  • 批准号:
    nhmrc : 1140147
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.44万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Michael Michael
  • 依托单位:
A randomised phase III trial of preoperative chemoradiotherapy vs preoperative chemotherapy for resectable gastric cancer
  • 批准号:
    nhmrc : 1046425
  • 项目类别:
    Project Grants
  • 资助金额:
    $138.3万
  • 财政年份:
    2013
  • 负责人:
    A/Pr Michael Michael
  • 依托单位:
The TOPGEAR trial; trial of preoperative therapy for gastric and esophagogastric junction adenocarcinoma
  • 批准号:
    nhmrc : GNT1046425
  • 项目类别:
    Project Grants
  • 资助金额:
    $197.46万
  • 财政年份:
    2013
  • 负责人:
    A/Pr Michael Michael
  • 依托单位:
Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests
  • 批准号:
    nhmrc : 1006242
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.17万
  • 财政年份:
    2011
  • 负责人:
    A/Pr Michael Michael
  • 依托单位:
海外基金